NCT03879304

Brief Summary

Duchenne's Muscular Dystrophy and Becker Dystrophy, hereafter DMD and BMD, is a serious and progressive disease that affects 1 in 3,500-6,000 males born alive. Scale 6-minute walking test, is used for determine the inclusion of children with DMD in pharmacological studies. Furthemore, is used to verify a training effectiveness assessing muscular endurance and cardio-respiratory functions. This Research evaluates the feasibility and effectiveness of a multimodal physiotherapist program with virtual reality glasses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 9, 2019

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 18, 2019

Completed
2 years until next milestone

Study Start

First participant enrolled

March 15, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 11, 2023

Completed
Last Updated

May 13, 2024

Status Verified

May 1, 2024

Enrollment Period

1.6 years

First QC Date

March 9, 2019

Last Update Submit

May 9, 2024

Conditions

Keywords

Virtual Reality [L01.224.160.875], [L01.296.555]Physical Therapy Modalities [E02.779], [E02.831.535]Respiratory Therapy [E02.880]Dystrophin [D12.776.210.500.250]Becker Muscular Dystrophy [C10.668.491.175.500.300]Resistance training [E02.831.535.483.875]Muscular Stretching Therapy [E02.831.535.483.750]

Outcome Measures

Primary Outcomes (1)

  • Changes in six meter walking test (6-MWT) score

    Six-meter walking test is a a well-established outcome measure in a variety of diseases. It is accurate, reproducible, simple to administer, and well tolerated. The 6MWT is a robust assessment tool for use in clinical trials given its ability to quantitatively evaluate ambulation in a controlled environment.

    Baseline, up to six weeks

Secondary Outcomes (4)

  • EPInfant

    through study completion, average 6 weeks

  • NSAA o North Star Ambulatory Assessment

    Baseline, up to 6 weeks

  • MFM o Motor Function Measure

    Baseline, up to 6 weeks

  • Kids Screen-52

    Baseline.

Study Arms (2)

Multimodal physiotherapy program with RV

EXPERIMENTAL

The RV intervention group receives a tele multimodal physiotherapy program with tradicional exercises of physiotherapy like stretching, aerobic, training through videos and gamification with VR glasses.

Other: multimodal physiotherapy program with RV

Traditional physiotherapy program

ACTIVE COMPARATOR

Traditional intervention group receives assistance of a program of physiotherapy traditional without virtual reality glasses.

Other: traditional physiotherapy program

Interventions

Physiotherapy Programm includes: respiratory physiotherapy, stretching, resistance training, aerobic training and adaptation and training with virtual reality glasses and relaxation.

Multimodal physiotherapy program with RV

Multimodal physiotherapy Programm includes: traditional physiotherapy, stretching, massage.

Traditional physiotherapy program

Eligibility Criteria

Age4 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children between 4 and 15 years
  • Duchenne and Becker Diagnosis ICD-10 issued by specialist in neurology.
  • Children who can walk 10 m at last 120 seconds.
  • First punctuation of North Start Ambulatory assessment bigger than 20 points.

You may not qualify if:

  • An other Dystrophies.
  • Older than 10 years.
  • Not Physiotherapy. Not walk.
  • Asociated heart disease Sprains, fractures. FC \>120, Sat O2 \<89%.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad de Málaga

Málaga, 29071, Spain

Location

Related Publications (2)

  • Baeza-Barragan MR, Labajos Manzanares MT, Ruiz Vergara C, Casuso-Holgado MJ, Martin-Valero R. The Use of Virtual Reality Technologies in the Treatment of Duchenne Muscular Dystrophy: Systematic Review. JMIR Mhealth Uhealth. 2020 Dec 8;8(12):e21576. doi: 10.2196/21576.

    PMID: 33289679BACKGROUND
  • Baeza-Barragan MR, Labajos Manzanares MT, Amaya-Alvarez MC, Morales Vega F, Rodriguez Ruiz J, Martin-Valero R. Effectiveness of a 5-Week Virtual Reality Telerehabilitation Program for Children With Duchenne and Becker Muscular Dystrophy: Prospective Quasi-Experimental Study. JMIR Serious Games. 2023 Nov 15;11:e48022. doi: 10.2196/48022.

MeSH Terms

Conditions

Muscular Dystrophy, Duchenne

Condition Hierarchy (Ancestors)

Muscular DystrophiesMuscular Disorders, AtrophicMuscular DiseasesMusculoskeletal DiseasesNeuromuscular DiseasesNervous System DiseasesGenetic Diseases, X-LinkedGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Rocío Martín Valero, PhD

    Universidad de Málaga

    STUDY DIRECTOR
  • Maria Teresa Labajos Manzanares, PhD

    Universidad de Málaga

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Twelve participants were randomized to follow a multimodal physiotherapy program for 6 weeks. At the end of this period the participants will be crossed to another intervention without virtual reality glasses. The results will be measured before and after each intervention during the study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 9, 2019

First Posted

March 18, 2019

Study Start

March 15, 2021

Primary Completion

October 30, 2022

Study Completion

March 11, 2023

Last Updated

May 13, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

an average of 2 years

Locations